$8.03
-0.35-4.18%
At close: -
$8.03
0.000.00%
After Hours: Feb 21, 4:00 PM EDT
Enanta Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Enanta Pharma using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q1 | 2025-02-10 | $-1.05 | $-1.35 | 22.2 % |
Q4 | 2024-11-25 | $-1.36 | $-1.41 | 3.55 % |
Q3 | 2024-08-05 | $-1.07 | $-1.45 | 26.2 % |
Q2 | 2024-05-06 | $-1.47 | $-1.33 | -10.5 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q1 | 2025-02-10 | $16.96M | $17.25M | -1.69 % |
Q4 | 2024-11-25 | $14.61M | $16.07M | -9.10 % |
Q3 | 2024-08-05 | $17.97M | $17.18M | 4.60 % |
Q2 | 2024-05-06 | $17.05M | $16.52M | 3.23 % |
Enanta Pharma (ENTA) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on February 10, 2025 for Q1.
The Actual EPS was $-1.05, which beat the estimate of $-1.35.
The Actual Revenue was $17M, which missed the estimate of $17.3M.
Browse earnings estimates, EPS, and revenue on all stocks.